1026421-63-5

Basic information

• Product Name: Phosphoric acid (R)-2-benzyloxy-3-hexadecyloxy-propyl ester (S)-2,3-dihydroxy-propyl ester
• CAS NO: 1026421-63-5
• Molecular Weight: 560.709
• Mol File: 1026421-63-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Phosphoric acid (R)-2-benzyloxy-3-hexadecyloxy-propyl ester (S)-2,3-dihydroxy-propyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Phosphoric acid (R)-2-benzyloxy-3-hexadecyloxy-propyl ester (S)-2,3-dihydroxy-propyl ester(1026421-63-5)
• EPA Substance Registry System: Phosphoric acid (R)-2-benzyloxy-3-hexadecyloxy-propyl ester (S)-2,3-dihydroxy-propyl ester(1026421-63-5)

Safety Data

• Hazardous Substances Data: 1026421-63-5(Hazardous Substances Data)

Upstream product

• 36653-82-4 1-Hexadecanol 
• 84415-89-4 (S)-2-benzyloxy-3-hexadecyloxy-propan-1-ol 
• 120019-37-6 3-hexadecyloxy-2R-hydroxypropyl 1-para-toluenesulphonate 
• 121469-38-3 1-O-hexadecyl-2-O-benzyl-sn-glycerol 3-O-p-toluenesulfonate 
• 137540-90-0 2-O-Benzyl-1-O-hexadecyl-3-O-(4-methoxybenzyl)-sn-glycerol 
• 145454-62-2 (R)-2-(benzyloxy)-3-[(4-methoxybenzyl)oxy]propan-1-ol 

Relevant articles and documents

Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue

The clinical use of anticancer lipids is severely limited by their ability to cause lysis of red blood cells prohibiting intravenous injection. Novel delivery systems are therefore required in order to develop anticancer ether lipids (AELs) into clinicall